Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
StakeWise Recovers $21M in Balancer Hack Funds— Can This Boost ETH Price?
StakeWise Recovers $21M in Balancer Hack Funds— Can This Boost ETH Price?

StakeWise successfully recovered $20.7 million in osETH and osGNO tokens following the $120 million Balancer V2 exploit. The funds will be returned to victims, confirming partial recovery.

BeInCrypto·2025/11/03 19:40
Forget Crypto — Bitcoin Miners Just Became America’s AI Powerhouses
Forget Crypto — Bitcoin Miners Just Became America’s AI Powerhouses

Bitcoin mining companies are rallying as they transition to AI infrastructure. IREN's $9.7 billion Microsoft agreement highlights the sector's transformation, while US chip export restrictions to China favor domestic operators.

BeInCrypto·2025/11/03 18:07
Flash
20:11
According to documents submitted to the U.S. Securities and Exchange Commission (SEC), Viridian Therapeutics, Inc. has reached an agreement with WuXi Biologics, which will manufacture and supply Viridian's investigational drug Veligrotug.
This collaboration marks a crucial step for Viridian in advancing the development and future commercialization of its core pipeline product, Veligrotug. By partnering with the global leading Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics, Viridian aims to ensure high-quality and scalable manufacturing capacity for its candidate drug.Veligrotug is a highly anticipated candidate therapy within Viridian’s pipeline. The implementation of this manufacturing supply agreement not only provides strong material support for subsequent clinical trials, but also paves the way for potential commercial launch. For biotech companies, securing manufacturing capacity with internationally recognized partners is an important strategic move to reduce R&D risks and accelerate product progression.The disclosure of this SEC filing communicates Viridian’s tangible progress in business operations to the market. Investors typically pay close attention to such collaborations involving the construction of core product supply chains, viewing them as key evidence for evaluating the company’s execution capabilities and future development potential.
20:11
BILL HOLDINGS INC announces new executive appointments and organizational structure updates aimed at supporting the company's next phase of business growth.
This adjustment involves the appointment of the leadership team to strengthen strategic execution capabilities and drive future development. By optimizing its internal structure, the company aims to enhance operational efficiency and lay a solid foundation for continued expansion. This series of measures reflects the company's determination to actively adapt to market changes and seize growth opportunities.
20:11
ICON has officially scheduled its 2025 Q4 and full-year earnings conference call, while also confirming receipt of a deficiency notice from the Nasdaq Stock Market regarding failure to meet continued listing standards.
The company stated that it is actively assessing the relevant situation and will take necessary measures to regain compliance with Nasdaq's listing rules.
News